Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Barbara G, Kravitz"'
Autor:
Shailesh Pitale, Mathew Thomas, Gaurav Rathi, Vaishali Deshmukh, Prasanna Kumar, Sanjay Reddy, Naresh Shetty, Atul Kakar, Sushrut Babhulkar, Bharat Mody, Jacob Chacko, Sudeep Acharya, Sadhna Joglekar, Vipul Halbe, Barbara G Kravitz, Brian Waterhouse, Antonio J Nino, Lorraine A Fitzpatrick
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 19, Iss 1, Pp 148-154 (2015)
Introduction: Osteoporosis is a serious condition affecting up to 50% of Indian postmenopausal women. Denosumab reduces bone resorption by targeting the receptor activator of nuclear factor-κB ligand. This study assessed the efficacy and safety of d
Externí odkaz:
https://doaj.org/article/a56deda1b23849fcb7a93433dece710c
Autor:
Mathew Thomas, Prasanna Kumar, Sanjay Reddy, Sushrut Babhulkar, Vipul Halbe, Sudeep Acharya, B. S. Mody, Naresh Shetty, Antonio Nino, Vaishali Deshmukh, Sadhna J Joglekar, Lorraine A. Fitzpatrick, Jacob Chacko, Barbara G. Kravitz, Gaurav Rathi, Shailesh Pitale, Brian Waterhouse, Atul Kakar
Publikováno v:
Indian Journal of Endocrinology and Metabolism
Indian Journal of Endocrinology and Metabolism, Vol 19, Iss 1, Pp 148-154 (2015)
Indian Journal of Endocrinology and Metabolism, Vol 19, Iss 1, Pp 148-154 (2015)
Introduction: Osteoporosis is a serious condition affecting up to 50% of Indian postmenopausal women. Denosumab reduces bone resorption by targeting the receptor activator of nuclear factor-κB ligand. This study assessed the efficacy and safety of d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1526bd3eb54a550e342174b3bb04d1c2
http://europepmc.org/articles/PMC4287760
http://europepmc.org/articles/PMC4287760
Autor:
Bernard Zinman, Giancarlo Viberti, John M. Lachin, Steven E. Kahn, Gitanjali Paul, Rury R. Holman, Nigel P. Jones, Barbara G. Kravitz, William H. Herman, Steven M. Haffner, R. Paul Aftring
CONTEXT: An increase in bone fractures has been observed in women taking thiazolidinediones. OBJECTIVE: The objective of the study was to examine whether changes in circulating bone biomarkers provide insight into the underlying mechanisms responsibl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8760809a858dc67ed9030b76521b7cce
https://doi.org/10.1210/jc.2009-0572
https://doi.org/10.1210/jc.2009-0572
Autor:
John M. Lachin, Steven E. Kahn, Bernard Zinman, Dahong Yu, Rury R. Holman, Giancarlo Viberti, Barbara G. Kravitz, Nigel P. Jones, M. Colleen O’Neill, Martin I. Freed, Steven M. Haffner, William H. Herman
The inflammatory factor C-reactive protein (CRP) and the fibrinolytic variables fibrinogen and plasminogen activator-1 (PAI-1) are associated with long-term cardiovascular morbidity. To determine the contribution of body adiposity (BMI), insulin sens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f3a1bf06495ced80befab1c0f5155e9
https://doi.org/10.2337/db06-0116
https://doi.org/10.2337/db06-0116
Autor:
John M, Lachin, Giancarlo, Viberti, Bernard, Zinman, Steven M, Haffner, R Paul, Aftring, Gitanjali, Paul, Barbara G, Kravitz, William H, Herman, Rury R, Holman, Steven E, Kahn
Publikováno v:
Clinical Journal of the American Society of Nephrology. 6:1032-1040
BACKGROUND AND OBJECTIVES: In ADOPT (A Diabetes Outcomes Prevention Trial), initial monotherapy with rosiglitazone provided more durable glycemic control than metformin or glyburide in patients with recently diagnosed type 2 diabetes. Herein, we exam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2dc49e31caa3db266992f86a46285635
https://doi.org/10.2215/cjn.09291010
https://doi.org/10.2215/cjn.09291010
Autor:
Giancarlo Viberti, William H. Herman, Bernard Zinman, Steven E. Kahn, Steven M. Haffner, Gitanjali Paul, Rury R. Holman, John M. Lachin, Barbara G. Kravitz, R. Paul Aftring
Publikováno v:
Diabetes
OBJECTIVE ADOPT (A Diabetes Outcome Progression Trial) demonstrated that initial monotherapy with rosiglitazone provided superior durability of glycemic control compared with metformin and glyburide in patients with recently diagnosed type 2 diabetes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b04c8d60a2cead92f1ac608a8b14e855
https://doi.org/10.2337/db10-1392
https://doi.org/10.2337/db10-1392
Autor:
Richard W. Nesto, Scot Garg, Barbara G. Kravitz, Diane Miller, Hector M. Garcia-Garcia, Robert E. Ratner, Salvatore Brugaletta, Nikheel S. Kolatkar, Patrick W. Serruys, Chun Huang, Giorgio Morocutti
Publikováno v:
The International Journal of Cardiovascular Imaging
International Journal of Cardiovascular Imaging, 28(3), 455-465. Springer Netherlands
International Journal of Cardiovascular Imaging, 28(3), 455-465. Springer Netherlands
To determine (1) the medium-term effect of rosiglitazone and glipizide on intra-stent neointima hyperplasia, (2) restenosis pattern as assessed by intra-vascular ultrasound (IVUS) and quantitative coronary angiography (QCA) in patients with T2DM and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7aef0c5946c51f23e018ed28aaa3adc4
http://europepmc.org/articles/PMC3326367
http://europepmc.org/articles/PMC3326367
Autor:
Steven E. Kahn, Gitanjali Paul, Bernard Zinman, John M. Lachin, William H. Herman, Giancarlo Viberti, Rury R. Holman, Barbara G. Kravitz, Dahong Yu, Steven M. Haffner
Publikováno v:
Diabetes Care. 33:177-183
OBJECTIVE C-reactive protein (CRP) is closely associated with obesity and cardiovascular disease in both diabetic and nondiabetic populations. In the short term, commonly prescribed antidiabetic agents have different effects on CRP; however, the long
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::11249a690d25686fb7b91e2067ca725a
https://doi.org/10.2337/dc09-1661
https://doi.org/10.2337/dc09-1661
Autor:
Robert E, Ratner, Christopher P, Cannon, Hertzel C, Gerstein, Richard W, Nesto, Patrick W, Serruys, Gerrit-Anne, Van Es, Nikheel S, Kolatkar, Barbara G, Kravitz, Andrew, Zalewski, Peter J, Fitzgerald, Debra, Mattioli
Publikováno v:
American Heart Journal, 156(6), 1074-1079. Mosby Inc.
Background Rosiglitazone, a thiazolidinedione, has effects on insulin sensitivity and cardiovascular risk factors that may favorably impact the progression of coronary atherosclerosis. Methods APPROACH is a double-blind randomized clinical trial comp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b90018eb18be82b85d6a41c361a0b3ab
https://doi.org/10.1016/j.ahj.2008.07.025
https://doi.org/10.1016/j.ahj.2008.07.025
Autor:
Heise Ma, Steven E. Kahn, Bernard Zinman, O'Neill Mc, John M. Lachin, Nigel P. Jones, William H. Herman, Barbara G. Kravitz, Steven M. Haffner, Rury R. Holman, Giancarlo Viberti
Publikováno v:
New England Journal of Medicine. 355:2427-2443
BACKGROUND: The efficacy of thiazolidinediones, as compared with other oral glucose-lowering medications, in maintaining long-term glycemic control in type 2 diabetes is not known. METHODS: We evaluated rosiglitazone, metformin, and glyburide as init
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba65749011cd761e9376a60ea089aeb2
https://doi.org/10.1056/nejmoa066224
https://doi.org/10.1056/nejmoa066224